Beyond COVID Vaccines – mRNA Therapeutics & Lean Strategies for their Non-Clinical (Safety) Assessments
Time: 1:45 pm
day: Day One Track A PM
Details:
- Introduction into special considerations for mRNA therapeutics with regards to their non-clinical PD/DMPK and safety assessments
- Introduction of the platform toxicology concept
- Challenges and opportunities for mRNA therapeutics in the non-clinical (safety) space
